diethanolamine has been researched along with Liver Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amacher, DE; Wang, B; Whittaker, MH | 1 |
| Hino, M; Ichihara, H; Matsumoto, Y; Ueoka, R | 1 |
| Becker, RA; Hays, SM; Hughes, B; Kirman, CR | 1 |
| Newberne, PM | 1 |
1 review(s) available for diethanolamine and Liver Neoplasms
| Article | Year |
|---|---|
Choline deficiency associated with diethanolamine carcinogenicity.
Topics: Animals; Carcinogens; Carcinoma, Hepatocellular; Choline Deficiency; Ethanolamines; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred Strains | 2002 |
3 other study(ies) available for diethanolamine and Liver Neoplasms
| Article | Year |
|---|---|
Derivation of a No-Significant-Risk-Level (NSRL) for diethanolamine (DEA).
Topics: Animals; California; Carcinogens; Ethanolamines; Female; Government Regulation; Humans; Liver Neoplasms; Male; Mice; Mutagenicity Tests; Rats; Rats, Inbred F344; Risk Assessment; Skin; Skin Absorption; State Government | 2014 |
Therapeutic effects of cationic hybrid liposomes on the hepatic metastasis of colon carcinoma along with apoptosis in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cations; Colonic Neoplasms; Dimyristoylphosphatidylcholine; Ethanolamines; HCT116 Cells; Humans; Liposomes; Liver; Liver Neoplasms; Mice; Mice, Inbred BALB C; Polyethylene Glycols | 2014 |
Derivation of a No-significant-risk-level (NSRL) for dermal exposures to diethanolamine.
Topics: Administration, Cutaneous; Animals; Carcinogenicity Tests; Dose-Response Relationship, Drug; Epigenesis, Genetic; Ethanolamines; Humans; Kidney Neoplasms; Liver Neoplasms; Mice; Models, Biological; No-Observed-Adverse-Effect Level; Risk Assessment; Skin; Skin Absorption; Species Specificity | 2016 |